18 May 2013
Keywords: Ras oncogene, Genentech, Roche
Article | 04 December 2011
A drug discovery team at Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX) has uncovered a chink in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 December 2011
5 December 2011
17 May 2013
© 2013 thepharmaletter.com